Fino al 60% di sconto su Profit Pro - Offerta a Tempo Limitato!
Saldi Invernali

60% di sconto su Profit Pro - Offerta a Tempo Limitato!

Aligos Therapeutics Inc

Aligos Therapeutics Inc

ALGS · NASDAQ
ALGS · NASDAQ

Guadagni successivi: 10 mar 2025

43.80
USD4.5311.54%

One Corporate Drive, South San Francisco, CA, United States, 94080

Dipendenti a tempo pieno

68

Settore GIC

Health Care

Gruppo GIC

Pharmaceuticals, Biotechnology & Life Sciences

Settore

Biotechnology

Esecutivi di alto livello

Nome

Titolo

Anno di nascita

Dr. Lawrence M. Blatt MBA, Ph.D.

CEO, President & Chairman of the Board

1962

Dr. Julian A. Symons DPHIL

Executive VP & Chief Scientific Officer

1961

Ms. Lesley Ann Calhoun CPA

Executive VP & CFO

1966

Ms. Kristina Engeseth M.B.A.

VP and Head of People & Culture

-

Dr. Sushmita M. Chanda DABT, Ph.D.

Executive Vice President & Chief Development Officer

1967

Dr. David B. Smith Ph.D.

Executive VP & Head of Chemical Operations

-

Dr. Tse-I Lin Ph.D.

VP of Early Compound Development & Belgian Site Head

-

Dr. Hardean E. Achneck M.D.

Chief Medical Officer

-